Get to know us

Our Researchers Groups

A diverse team of scientists and innovators dedicated to advancing biotechnology and nanomedicine.

Frederico Pittella Silva

Based at the Federal University of Juiz de Fora (UFJF), focuses on the development of RNA interference (RNAi) therapies for breast cancer using advanced nanoparticle delivery systems. Led by Dr. Frederico Pittella Silva, the team includes postdoctoral and doctoral researchers who are pioneering novel approaches for targeted gene silencing. Their projects combine nanotechnology, molecular biology, and therapeutic design, emphasizing translational applications and high-impact innovations in RNA-based therapeutics.

Natália Prado da Silva

Pós-doc

Lívia Mara Silva

PhD student

Davi Trombini Aleixo

PhD student

Estael Cruz Cazarim

PhD student

Kezia Cristine Barbosa

PhD student

Lívia do Nascimento Grossi

PhD student

Allana Carvalho Silva

PhD student

Silvia Ligorio Fialho

Operating at Funed, specializes in ocular drug delivery and preclinical evaluation of intravitreal therapies. Under the leadership of Silvia Ligorio Fialho, the group develops protein-loaded liposomes and intravitreal devices coated with nanofibers, aiming to treat retinal vein occlusion and age-related macular degeneration. Their work integrates nanomaterials, biomedical engineering, and in vivo safety studies, supporting the creation of a research core for biopharmaceutical development.

Marina França Dias

Researcher

Lutiana Amaral de Melo

Researcher

Maria Carolina Guerra

Researcher

Deivisson Fagundes

Master's student

Gabriela Pierazoli

undergrad

Amaury Souza

undergrad

Mauro Aparecido de Sousa Xavier

Based at UNIMONTES, focuses on vaccine development, particularly recombinant multi-epitope vaccines against Rhipicephalus microplus. Led by Mauro Aparecido de Sousa Xavier, the team combines collaborative efforts in molecular immunology and protein engineering, designing innovative vaccine platforms and alternative strategies, with an emphasis on translational applications in disease prevention.

Alessandra Xavier

Collaborator

Viviane Andrade

Collaborator

Fábio Ribeiro

Collaborator

Léia Cardoso

PhD student

Mayka Rabelo

Collaborator

Luciana Maria Silva Lopes

Operating at Funed, is dedicated to cancer therapeutics using gene editing technologies. Led by Luciana Maria Silva Lopes, the team explores STAT3 gene inactivation via CRISPR/Cas9 in 3D tumor spheroids enriched with cancer stem cells (CD44+/CD24-/low). Their research integrates molecular biology, stem cell technologies, and translational oncology, aiming to discover new therapeutic approaches for aggressive cancers and advancing preclinical modeling tools.

Milene Pereira Moreira

Researcher

Bianca Nataliene Carvalho de Camargos

Master's student

Julia Guerra Vieira de Sousa

Master's student

Estael Cruz Cazarim

PhD student

Kezia Cristine Barbosa

PhD student

Lívia do Nascimento Grossi

PhD student

Allana Carvalho Silva

PhD student

Armando da Silva Cunha Junior

Based at UFMG, focuses on innovative gene therapy and nanomedicine approaches for ocular disorders, including hereditary retinal dystrophies and age-related macular degeneration. Led by Armando da Silva Cunha Junior, the group develops non-viral gene transfer vectors, polymeric nanofibers loaded with bevacizumab, and alternative drug delivery systems. Their work combines biomaterials, pharmacology, and therapeutic engineering to create cutting-edge ocular therapeutics.

Carolina Nunes da Silva

Researcher (DTI)

Ana Carolina Guimaraes Ribeiro

Researcher (PDJ)

Thomas Toshio Inoue

PhD

Michelle Gouvêa Gomes

PhD

Ana Luiza Faria Silvério

Undergrad student

Vitória Luísa Lopes de Souza

Undergrad student

Larissa Santos Covre Stefanon

ADC 2A

Matheus Souza Gomes

Operating at the Federal University of Uberlândia (UFU), PADM2 is centered on bioinformatics and RNA-based technologies. Led by Dr. Matheus S. Gomes, the team develops tools for RNA selection of siRNA (siRNA Seeker) and miRNA, in a web-based aproach, integrating computational biology, data science, and molecular genetics. In addition, the group carries out a 3D protein modeling project powered by the MOE software, enhancing structural analysis and drug design capabilities. The focus is on enabling precision RNA therapeutics and advancing digital tools for gene regulation research.

Catarina Ribeiro Rezende de Freitas

Undergrad student

Valdeir Braz de Paula

Undergrad student

Laurence Rodrigues do Amaral

Collaborator

Pedro Luiz Lima Bertarini

Collaborator

Carlos Bruno de Araújo

PhD student

Discover Our Future Tools

See what other cool tools we're working on while you browse through our ongoing projects.

Check Out Our Projects